1. Home
  2. ELMD vs SABS Comparison

ELMD vs SABS Comparison

Compare ELMD & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$23.07

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELMD
SABS
Founded
1992
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.2M
201.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ELMD
SABS
Price
$23.07
$3.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$36.00
$9.80
AVG Volume (30 Days)
42.6K
654.4K
Earning Date
02-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
N/A
EPS
0.56
N/A
Revenue
$54,716,000.00
N/A
Revenue This Year
$15.59
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
$41.86
N/A
Revenue Growth
13.83
N/A
52 Week Low
$17.73
$1.00
52 Week High
$30.73
$6.60

Technical Indicators

Market Signals
Indicator
ELMD
SABS
Relative Strength Index (RSI) 40.71 43.61
Support Level $17.87 $3.52
Resistance Level $25.38 $4.16
Average True Range (ATR) 0.76 0.30
MACD 0.09 -0.04
Stochastic Oscillator 16.67 6.62

Price Performance

Historical Comparison
ELMD
SABS

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: